Utilization of colon cancer screening following genetic testing for HNPCC mutations.

被引：0
|
作者：
Hughes, C
Lynch, H
Kucharski, S
Main, D
Lerman, C
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Creighton Univ, Omaha, NE 68178 USA
[3] DP Clin Associates, Rockville, MD USA
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2002年 / 11卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B131
引用
收藏
页码：1175S / 1175S
页数：1
相关论文
共 50 条
  • [41] Screening and genetic counseling practices for hereditary non-polyposis colorectal cancer (HNPCC)
    Karri, S.
    Govindarajan, S. R.
    Bendure, W. B.
    Jackson, S. A.
    McKelvey, K. D.
    Govindarajan, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Colon cancer screening by fecal immunochemical testing in Iran
    Salimzadeh, H.
    Bishehsari, F.
    Sauvaget, C.
    Amani, M.
    Hamzeloo, R.
    Nikfarjam, A.
    Maziar, M.
    Merat, S.
    Delavari, A.
    Malekzadeh, R.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [43] Costs and Barriers of Cancer Screening After Positive Genetic Testing: Are Actionable Mutations Becoming "Unactionable"?
    Kahn, Ryan M.
    Gordhandas, Sushmita
    Aviki, Emeline
    Roche, Kara Long
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 616 - 617
  • [44] Identification and utilization of genetic mutations in the treatment of ovarian cancer
    Johnson, A.
    Hawkins, G. M.
    Kouri, A.
    Clark, L. H.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 159 : 267 - 267
  • [45] Identification and Utilization of Genetic Mutations in the Treatment of Ovarian Cancer
    Johnson, A.
    Hawkins, G. M.
    Kouri, A.
    Clark, L. H.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 158 (01) : E12 - E13
  • [46] Cancer screening behaviour of people taking place in genetic counselling for hereditary nonpolyposis colorectal cancer (HNPCC)
    Deges, G.
    Elbert, I
    Keller, M.
    Alberti, L.
    Hasenbring, M.
    [J]. PSYCHO-ONCOLOGY, 2006, 15 (02) : S218 - S219
  • [47] Impact of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC)
    Halliday, JL
    Meiser, B
    Warren, R
    Collins, VR
    Gaff, C
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 312 - 312
  • [48] GENETIC SCREENING OF PATIENTS WITH CONGENITAL GH DEFICIENCY IN THE GENESIS OBSERVATIONAL PROGRAM: CLINICAL INDICATORS FOR IDENTIFICATION OF MUTATIONS.
    Blum, Werner F.
    Child, Christopher J.
    Klammt, Juergen
    Pfaeffle, Heike M.
    Amselem, Serge
    Legendre, Marie
    Sobrier, Marie-Laure
    Jones, Christine
    Zimmerman, Alan G.
    Pfaeffle, Roland W.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 114 - 115
  • [49] Development and pilot testing of a decision aid for genetic testing for hereditary non-polyposis colorectal cancer (HNPCC)
    Wakefield, C
    Meiser, B
    Homewood, J
    Kirk, J
    Tucker, K
    [J]. PSYCHO-ONCOLOGY, 2004, 13 (08) : S82 - S83
  • [50] Genetic Testing by Cancer Site Colon (Polyposis Syndromes)
    Jasperson, Kory W.
    [J]. CANCER JOURNAL, 2012, 18 (04): : 328 - 333
12345